Christopher A. Chapleau
Affiliations: | University of Alabama, Birmingham, Birmingham, AL, United States |
Area:
dendritic spines/ mental retardationGoogle:
"Christopher Chapleau"Mean distance: 14.93 (cluster 6) | S | N | B | C | P |
Parents
Sign in to add mentor| Daniel P. Miller | research assistant | 2000-2002 | Carthage College | |
| Lucas Pozzo-Miller | grad student | 2003-2008 | UAB | |
| (The developmental functions of BDNF and MeCP2 on dendritic and synaptic structure.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Medeiros D, Ayala-Baylon K, Egido-Betancourt H, et al. (2024) A small-molecule TrkB ligand improves dendritic spine phenotypes and atypical behaviors in female Rett syndrome mice. Disease Models & Mechanisms. 17 |
| Medeiros D, Ayala-Baylon K, Egido-Betancourt H, et al. (2023) A small-molecule TrkB ligand improves dendritic spine phenotypes and atypical behaviors in female Rett syndrome mice. Biorxiv : the Preprint Server For Biology |
| Ferreras S, Fernández G, Danelon V, et al. (2017) Cdk5 Is Essential for Amphetamine to Increase Dendritic Spine Density in Hippocampal Pyramidal Neurons. Frontiers in Cellular Neuroscience. 11: 372 |
| Arnold M, Cross R, Singleton KS, et al. (2016) The Endosome Localized Arf-GAP AGAP1 Modulates Dendritic Spine Morphology Downstream of the Neurodevelopmental Disorder Factor Dysbindin. Frontiers in Cellular Neuroscience. 10: 218 |
| Bello O, Blair K, Chapleau C, et al. (2013) Is memantine a potential therapeutic for Rett syndrome? Frontiers in Neuroscience. 7: 245 |
| Chapleau CA, Lane J, Larimore J, et al. (2013) Recent Progress in Rett Syndrome and MeCP2 Dysfunction: Assessment of Potential Treatment Options. Future Neurology. 8 |
| Chapleau CA, Lane J, Pozzo-Miller L, et al. (2013) Evaluation of current pharmacological treatment options in the management of Rett syndrome: from the present to future therapeutic alternatives. Current Clinical Pharmacology. 8: 358-69 |
| Larimore J, Ryder PV, Kim KY, et al. (2013) MeCP2 regulates the synaptic expression of a Dysbindin-BLOC-1 network component in mouse brain and human induced pluripotent stem cell-derived neurons. Plos One. 8: e65069 |
| Pitcher MR, Ward CS, Arvide EM, et al. (2013) Insulinotropic treatments exacerbate metabolic syndrome in mice lacking MeCP2 function. Human Molecular Genetics. 22: 2626-33 |
| Arnold JJ, Hansen MS, Gorman GS, et al. (2013) The effect of Rho-associated kinase inhibition on the ocular penetration of timolol maleate. Investigative Ophthalmology & Visual Science. 54: 1118-26 |